Dr. Giacomo Lanzoni, Ph.D.
Assistant Professor, Department of Biochemistry & Molecular Biology
Diabetes Research Institute, University of Miami Miller School of Medicine

Dr. Giacomo Lanzoni is a leading investigator focused on developing a functional cure for Type 1 Diabetes by protecting, replacing, and regenerating insulin-producing cells. His work harnesses immune modulation with mesenchymal stem cells (MSCs) and their extracellular vesicles to suppress deleterious immune responses and improve islet cell transplant outcomes. His therapeutic approach has demonstrated clinical efficacy in COVID-19 Acute Respiratory Distress Syndrome, a condition characterized by extremely elevated levels of inflammation and immune dysregulation. He is advancing localized immune protection strategies with pancreatic progenitors and stem-cell–derived islets to enable islet cell replacement at scale.

Trained at the University of Bologna (Ph.D. in Stem Cell Biotechnology), Dr. Lanzoni has published extensively, holds multiple patents, and earned international recognition. With over 17 years of translational experience bridging the laboratory and the clinic, his mission is to deliver innovative cell- and immune-based therapies that can transform the lives of people with diabetes and autoimmune conditions.